Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHUTCHMED (China) Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q2 2026 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2026 | 1 | -$1.02 | -$1.02 | -$1.02 |
| Q1 2027 | 1 | -$1.23 | -$1.23 | -$1.23 |
| Q2 2027 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2027 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q4 2027 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q1 2028 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2028 | 1 | $1.46 | $1.46 | $1.46 |
| Q3 2028 | 1 | $2.50 | $2.50 | $2.50 |
| Q4 2028 | 1 | $0.15 | $0.15 | $0.15 |
| Q1 2029 | 1 | $0.21 | $0.21 | $0.21 |
| Q2 2029 | 1 | $0.30 | $0.30 | $0.30 |
| Q3 2029 | 1 | $0.25 | $0.25 | $0.25 |
HUTCHMED (China) Limited Earnings Date And Information
HUTCHMED (China) Limited last posted its earnings results on Thursday, July 30th, 2026. The company reported $0.046 earnings per share for the quarter, missing analysts' consensus estimates of $0.145 by $0.099. The company had revenue of 139.14 M for the quarter and had revenue of 549.96 M for the year. HUTCHMED (China) Limited has generated $3 earnings per share over the last year ($2.6 diluted earnings per share) and currently has a price-to-earnings ratio of 132.99. HUTCHMED (China) Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
HUTCHMED (China) Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/30/2026 | Q2 2026 | $0.15 | $0.05 | -0.1 | $80.92 M | $139.14 M |
| 03/31/2026 | Q1 2026 | N/A | $0.05 | N/A | $80.92 M | $139.14 M |
| 03/05/2026 | Q4 2025 | $2.50 | $0.00 | -2.5 | $80.92 M | $135.42 M |
| 09/30/2025 | Q3 2025 | N/A | $0.01 | N/A | $57.28 M | $135.42 M |
| 08/07/2025 | Q2 2025 | $1.46 | $1.30 | -0.16 | $57.28 M | $138.84 M |
| 03/31/2025 | Q1 2025 | N/A | $1.30 | N/A | $57.28 M | $138.84 M |
| 03/19/2025 | Q4 2024 | $0.04 | $0.04 | 0 | $57.28 M | $162.26 M |
| 09/30/2024 | Q3 2024 | N/A | $0.04 | N/A | $53.62 M | $162.26 M |
| 07/31/2024 | Q2 2024 | -$0.39 | $0.08 | 0.47 | $53.62 M | $152.84 M |
| 03/31/2024 | Q1 2024 | N/A | $0.08 | N/A | $53.62 M | $152.84 M |
| 02/28/2024 | Q4 2023 | -$1.08 | -$0.20 | 0.88 | $53.62 M | $152.56 M |
| 09/28/2023 | Q3 2023 | N/A | -$0.20 | N/A | N/A | $80.25 M |
| 07/31/2023 | Q2 2023 | -$0.52 | $0.49 | 1.01 | N/A | $266.44 M |
| 03/31/2023 | Q1 2023 | N/A | $0.49 | N/A | N/A | $266.44 M |
| 02/28/2023 | Q4 2022 | -$1.02 | -$0.60 | 0.42 | N/A | $112.18 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.60 | N/A | N/A | $112.18 M |
| 08/01/2022 | Q2 2022 | -$1.02 | -$0.95 | 0.07 | N/A | $202.05 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.48 | N/A | N/A | $101.02 M |
| 03/03/2022 | Q4 2021 | -$0.73 | -$0.29 | 0.44 | N/A | $99.38 M |
| 09/29/2021 | Q3 2021 | N/A | -$0.27 | N/A | N/A | $99.38 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
HUTCHMED (China) Limited Earnings: FAQ's
The conference call for HUTCHMED (China) Limited's latest earnings report can be listened to online.
The conference call transcript for HUTCHMED (China) Limited's latest earnings report can be read online.
HUTCHMED (China) Limited (:HCM) has a recorded annual revenue of $549.96 M.
HUTCHMED (China) Limited (:HCM) has a recorded net income of $458.12 M.HUTCHMED (China) Limited has generated $2.65 earnings per share over the last four quarters.
HUTCHMED (China) Limited (:HCM) has a price-to-earnings ratio of 132.99 and price/earnings-to-growth ratio is -1.38.